DBP International: seeks international patent for the use of iron succinate
Double Bond Pharmaceutical AB (”Double Bond”) has filed a PCT patent application to protect the use of ferrous succinate for certain indications. Last year, a clinical study was conducted with collaboration between Double Bond and Skellefteå University, showed that iron succinate significantly improves iron uptake, iron saturation and iron storage in patients with heart failure and iron deficiency. Through its subsidiary Drugsson AB, Double Bond Pharmaceutical AB has the distribution rights for Inofer (iron succinate) in Sweden, Norway, Denmark and Finland. "We are pleased with